February 2014

11 February 2014

Applications are invited for PROJECT ASSOCIATE @ RGCB

The Rajiv Gandhi Centre for Biotechnology (RGCB) is a growing phenomenon. Located in Thiruvananthapuram, the capital city of Kerala, RGCB began in 1990 amongst humble surroundings as a small charitable society called the Centre for Development of Education, Science and Technology (C-DEST). In 1991, recognizing its potential, the C-DEST was made a “Grant-in-Aid” institute of the Government of Kerala and renamed as Rajiv Gandhi Centre for Development of Education, Science and Technology (RGC-DEST), becoming the first institute in the country to be named after Sri Rajiv Gandhi, the young illustrious and visionary former Prime Minster of India.

Post: PROJECT ASSOCIATE (IPR AND TECHNOLOGY DEVELOPMENT)

11 February 2014

Lower-intensity statin combination therapy may utilize for high-risk atherosclerotic cardiovascular disease

For atherosclerotic cardiovascular disease risk reduction, American College of Cardiology and the American Heart Association guidelines recommend initiating moderate or high-intensity statin monotherapy as the first-lin

11 February 2014

Mast Therapeutics acquire Aires Pharmaceuticals, Inc.

Mast Therapeutics, Inc., publicly traded biopharmaceutical company headquartered in San Diego, California, announced on 10th feb, 2014 that it has entered into a definitive agreement to acquire Aires Pharmaceuticals, Inc. (Aires), a privately-held, clinical stage pharmaceutical company developing therapies to treat pulmonary vascular disorders such as pulmonary arterial hypertension and pulmonary hypertension due to heart failure.

11 February 2014

SOY-BASED DIET: A MESMERIZING TRIUMPH FOR WELLNESS

There are three topics that can cause derision and division at any coffee or dinner table across the Western world: religion, politics, and soy. The humble soybean does have a noble and ingrained place in our world today and, whether you are pro or no, it’s almost unavoidable. Soy is everywhere - from your soy milks and tofus to the more discreet soy lecithin used to prevent compounds from separating during the cooking process.

10 February 2014

Vacancy in Birla Institute of Technology and Science for the post of Junior Research Fellow in SERB | M.Pharm

The Pharmacy department of BITS Pilani is one of the few early schools of Pharmacy in India. Established in 1950, under the able leadership of (Late) Prof. M. L. Schroff, Father of Pharmacy Education in India, it blossomed into one of the most sought after Schools of Pharmacy in India due to its broad-based education system and university-industry linkages, which is the hallmark of BITS, Pilani.
In the year of 2011, the Department of Pharmacy has completed 60 years of its existence as a premier institution in the field of Pharmacy Education and Research in India and abroad. Alumni are well placed in India as well as abroad in various pharmaceutical companies, government organizations like drug control, research laboratories, etc., and in several well-known academic institutions.

10 February 2014

Job as Production Executive(Parenterals/ Injection Dept.)- Contract Manufacturing in Well reputed pharma MNC

Our client has a huge range of products ranging from tablet formulations to sterile preparations

Post: Production Executive(Parenterals/ Injection Dept.)- Contract Manufacturing

10 February 2014

Require Pharmacists ( 3 posts) & Staff Nurse (12 posts) in District Health & Family Welfare Society

DH&FW Society (District Health & Family Welfare Society), Yamuna Nagar invites the applications from the eligible candidates for the following posts, purely on contractual basis under NRHM up to 31.03.2014 or till the completion of the project whichever is earlier. The Screened candidates on the basis of eligibility and written test will be eligible for interview.

10 February 2014

Job as MANAGER-Business Development in Collective Growth Realty Pvt Ltd - Strategic Division of Earth Infrastructures Ltd

Collective Growth Realty Pvt. Ltd. is a Marketing Strategy and Associates of EARTH INFRASTRUCTURES LTD..
EARTH INFRASTRUCTURES LTD. is an independent infrastructure provider with committed customer base backed by a group of dynamic investors from India and Overseas. It is one of India's most well capitalised Real Estate Company.

Post: MANAGER-Business Development

PharmaTutor (February- 2014)
ISSN: 2347 - 7881

Received On: 25/12/2013; Accepted On: 20/01/2014; Published On: 10/02/2014

Author: Languluri Reddenna¹*, Sree Nagavalli K²
¹Department of Pharmacy Practice, Rajiv Gandhi Institute of Medical Sciences, Kadapa, Andhra Pradesh, India-516003
²Department of Pharmacy Practice, S.J.M College of Pharmacy, Chitradurga, Karnataka, India-577502
*reddennapharmd@gmail.com

ABSTRACT: Asthma is one of the common diseases. Asthma was a term used by the ancient Greeks to describe any condition that causes shortness of breath. Early warning signs are breathing changes, sneezing, moodiness, headache, runny/stuffy nose, coughing, chin or throat itches, feeling tired, dark circles under eyes, trouble sleeping. Asthma creates an extensive burden on individuals and families, as it is more often under-diagnosed and under-treated. World Health Organization estimates that 300 million people suffer from asthma, 2, 55, 000 people died of asthma in 2005 and over 80% of Asthma deaths were reported from low and lower-middle income countries. In India, an estimated 57,000 deaths were attributed to asthma in 2004 and it is one of the leading causes of morbidity and mortality in rural India. India had an estimated 15-20 million asthmatics. It was estimated that the number of people with asthma would grow by more than 100 million by 2025.As members of the health care team, pharmacists are in an excellent position to recognize patients who are not under the care of a physician or whose asthma will poorly controlled for a variety of reasons. Particular resources are provided to improve the care of disadvantaged groups with high morbidity, including certain racial groups and those who are poorly educated, live in large cities, or are poor and to address preventable factors, such as air pollution, that trigger exacerbations of Asthma.

How to cite this article: L Reddenna, S Nagavalli, Management of Asthma: Role of Clinical Pharmacist, 2014, 2(2), 124-133

[ABSTRACT WITH CITATION] [VIEW AS HTML]

REFERENCES:
1. Joseph t. Dipiro - pharmacotherapy- sixth edition- publication 1999- chapter 26- page no.: 503- 535
2. Global initiative for asthma- updated 2010. Available from: ginasthma.org
3. sancd.org/uploads/pdf/Asthma_factsheet.pdfs
4. nationaljewish.org
5. Herfindal text book of therapeutics- drug and disease management. chapter 34.2006.
6. World health organization. Global surveillance, prevention and control of chronic respiratory diseases: a comprehensive approach, 2007
7. Harrison’s principles of internal medicine- 17th edition- published in 2008- chapter 248
8. World health organization. Global surveillance, prevention and control of chronic respiratory diseases: a comprehensive approach, 2007
9. medical-exam-essentials.com/current-asthma-treatment.html
10. Global initiative for asthma- updated 2010 (ginasthma.org)
11. Herfindal text book of therapeutics- drug and disease management- 2006th year edition- chapter 34.
12. ehow.com
13. aaaai.org -- American Academy of Allergy, Asthma & Immunology
14. Kabila B, Sankar V- Risk factor Assessment Study For Bronchial Asthma among the Rural People- Indian Journal of Pharmacy Practice- Volume 4- Issue 3- Jul to Sep, 2011
15. Voices.yahoo.com/prevent-asthma-attacks-through-diet-l... - united states 10 oct 2009
16. Tricia M. McKeever - 2004 The American Thoracic Society- Accepted July 12, 2004 (atsjournals.org)
17. webmd.com/asthma/guide/asthma-diet-what-you-should-know
18. asthma.about.com/od/asthmacam/a/asthma_diet.html
19. Global initiative for asthma- updated 2010 (ginasthma.org)
20. 29. KD Tripathi – Essentials Of Medical Pharmacology- 6th Edition- 2010 publication, Chapter 16- page No.: 213-237
21. Drug Today – January to March 2012- Volume II- Page No.: 893-913
22. CIMS- Jan to April. 2012- Page No.: 134- 152 ( cimsasia.com)
23. British National Formulary- March 2010- Page No.: 163- 185 (bnf.org)
24. National Center for Health Statistics. Current estimates from the National Health Interview Survey: United States. Vital and Health Statistics. Series 10. Washington, D.C. U.S.Government Printing Office. Issues from 1985-1993.
25. Weiss KB, Gergen PJ, Hodgson TA. An economic evaluation of asthma in the United States. New England Journal of Medicine 1992; 326:862-6.
26. Asthma—United States: 1980-90. Morbidity and Mortality Weekly Report 1992; 41:733 5.
27. National Heart, Lung, and Blood Institute, National Asthma Education Program, Expert Panel Report. Guidelines for the Diagnosis and Management of Asthma. NIH Publication No. 91-3042, August 1991.
28. Self TH, Brooks JB, Lieberman P, Ryan MR. The value of demonstration and role of the pharmacist in teaching current use of pressurized bronchodilators. Canadian Medical Association Journal 1983; 128:129-31.
29. Kesten S, Zive K, Chapman KR. Pharmacist knowledge and ability to use inhaled medication delivery systems. Chest 1993; 104:1737-42.
30. De Blaquiere P, Christensen DB, Carter WB, Martin TR. Use and misuse of metered-dose inhalers by patients with chronic lung disease. American Review of Respiratory Diseases 1989; 140:910-6.
31. Hindle M, Newton DA, Chrystyn H. Investigations of an optimal inhaler technique with the use of urinary salbutamol excretion as a measure of relative bioavailability to thelung.Thorax1993;48(6):607-10
32. Executive Committee, American Academy of Allergy and Immunology. Inhaled betaadrenergic agonists in asthma. Journal of Allergy and Clinical Immunology 1993; 91:1234-7.
33. Larsson S, Svedmyr N. Bronchodilating effect and side effects of beta2-adrenoceptor stimulants by different modes of administration (tablets, metered aerosol, and combinations thereof). American Review of Respiratory Diseases 1977; 116:861-9.
34. Weinberger M, Bronsky E. Interaction of ephedrine and theophylline. Clinical Pharmacology and Therapeutics 1975; 17:585-92.
35. Kabila B, Sankar V- Risk factor Assessment Study For Bronchial Asthma among The Rural People- Indian Journal of Pharmacy Practice- Volume 4- Issue 3- Jul to Sep, 2011
36. Tarig Hakim Merghani - Knowledge, attitude and behaviour of asthmatic patients regarding asthma in urban areas in Khartoum State, Sudan- Khartoum Medical Journal, 2011- vol.4No.:1- Pg No.:524-531
37. Jaime Correia de Sousaa,- Asthma incidence and accuracy of diagnosis in the Portuguese sentinel practice network- Primary Care Respiratory Journal (2010); 19(4): 352-357
38. Liebhart J et al - “Prevalence and Risk Factors for Asthma in Poland: Results From the PMSEAD Study” - J Investig Allergol Clin Immunol 2007; Vol. 17 (6): 367-374
39. Barnard C G et al - “Assessing individual employee risk factors for occupational asthma in primary aluminium smelting” - Occup Environ Med 2004;61:604–608. doi: 10.1136/oem.2003.009159
40. MarijaCrnc?evic´ Ureket - “Effect of educational programs on asthma control and quality of life in adult asthma patients” - Patient Education and Counseling 58 (2005) Page No.:47–54
41. Peter G. Gibson - “Asthma education” - Respiratory Medicine (2003) 97, 1036–1044
42. Andrew G - “Should patients with persistent severe asthma be monitored for medication adherence?” - VOLUME 94, FEBRUARY, 2005- Ann Allergy Asthma Immunol. 2005;94:251–257.
43. PrabhakaranL et al - Impact of an asthma education programme on patients’ knowledge, inhaler technique and compliance to treatment - Singapore Med J 2006- 47(3)- Page No.:225-231
44. Vijaya Kumar S - Drug utilization and prescription monitoring of asthma patients- Young Pharmacists 2009- Year : 2009 | Volume : 1 | Issue : 2 | Page : 180-183
45. Awanish Pandey- Prescription Pattern in Asthma Therapy At Gorakpur Hospitals Lung India- volume 7- Issue1 – Jan-March 2010(lungindia.com)
46. Roberto Cano-De La Cuerda,et al conducted a study on Effectiveness of Therapeutic Education and Respiratory Rehabilitation Programs for the Patient with Asthma- Arch Bronconeumol. 2010;46(11):600-606

10 February 2014

Career opportunity for Clinical Team Manager (Based in any APAC) in PPD Pharmaceuticals

PPD is a leading global contract research organization providing discovery, development and post-approval services as well as compound partnering programs. Our clients and partners include pharmaceutical, biotechnology, medical device, academic and government organizations. With offices in 32 countries and more than 9,000 professionals worldwide, PPD applies innovative technologies, therapeutic expertise and a commitment to quality to help its clients and partners maximize returns on their R&D investments and accelerate the delivery of safe and effective therapeutics to patients